Scientific Advisory Board (SAB)

The Lyme Research Alliance Scientific Advisory Board (SAB) is comprised of illustrious individuals drawn from the fields of medical research, medical practice and Lyme disease advocacy. Chaired by LRA’s Chief Scientific Officer, Harriet Kotsoris, M.D., the SAB provides advice on overall research strategy  to direct LRA’s grant funds into programs judged to have exceptional prospects of delivering measurable advances.

Charles Chiu, M.D., Ph.D. is Assistant Professor of Laboratory Medicine and Medicine/Infectious Diseases at UCSF, Director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC), and Associate Director of the UCSF Clinical Microbiology Laboratory. Dr. Chiu is an expert in development and implementation of advanced genomic technologies – microarrays and next-generation sequencing – for pathogen discovery and clinical assay validation in the microbiology laboratory, with over 50 patents and peer-reviewed publications on these topics. He has spoken at numerous national and international conferences on these topics, and is on an FDA task force on bloodborne pathogen screening for ensuring transfusion safety.

Allison DeLong joins LRA from Brown University, RI where she is a biostatistician at the Center for Statistical Sciences in the Department of Public Health.  With a MS degree in Applied Mathematics and Statistics, she is certified as a professional statistician by the American Statistical Association.

Judith Miklossy MD, Ph.D. is Director of the Alzheimer Research Center in Switzerland. Author of countless papers and reference works, she is an expert in spirochete microbiology and neuropathology.  Dr. Miklossy serves on the boards of several international Lyme disease foundations.   

Luc Montagnier Ph.D. is the co-winner of the 2008 Nobel Prize for Physiology or Medicine and the co-discoverer of the human immunodeficiency virus (HIV). Dr. Montagnier is currently studying signature electromagnetic wave patterns made by bacteria and viruses in the plasma of patients stricken with degenerative diseases, including Lyme disease.

Richard S. Ostfeld Ph.D. is Senior Scientist and Disease Ecologist at the Cary Institute of Ecosystem Studies, where he researches population and community dynamics of vertebrates and their impact on disease risk. He is an adjunct professor at the University of Connecticut and Rutgers University.

Mark J. Soloski Ph.D. is Professor of Medicine at Johns Hopkins University School of Medicine. Dr. Soloski is an expert basic immunologist with an interest in the host immune response to bacterial infection and how this response sets the stage for post-infectious chronic inflammatory disease.